BioLife Solutions (BLFS) Competitors $25.98 +0.18 (+0.70%) Closing price 04:00 PM EasternExtended Trading$25.98 0.00 (-0.02%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLFS vs. SLNO, TMDX, NVST, LIVN, WRBY, INSP, LQDA, PRCT, LMAT, and AORTShould you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), and Artivion (AORT). These companies are all part of the "medical equipment" industry. BioLife Solutions vs. Its Competitors Soleno Therapeutics TransMedics Group Envista LivaNova Warby Parker Inspire Medical Systems Liquidia Technologies PROCEPT BioRobotics LeMaitre Vascular Artivion BioLife Solutions (NASDAQ:BLFS) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Do institutionals and insiders believe in BLFS or SLNO? 93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by company insiders. Comparatively, 6.4% of Soleno Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, BLFS or SLNO? BioLife Solutions has a beta of 1.78, suggesting that its share price is 78% more volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.72, suggesting that its share price is 372% less volatile than the S&P 500. Do analysts prefer BLFS or SLNO? BioLife Solutions presently has a consensus price target of $31.29, indicating a potential upside of 20.42%. Soleno Therapeutics has a consensus price target of $115.09, indicating a potential upside of 131.52%. Given Soleno Therapeutics' higher probable upside, analysts clearly believe Soleno Therapeutics is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.08 Does the media refer more to BLFS or SLNO? In the previous week, Soleno Therapeutics had 22 more articles in the media than BioLife Solutions. MarketBeat recorded 36 mentions for Soleno Therapeutics and 14 mentions for BioLife Solutions. BioLife Solutions' average media sentiment score of 0.68 beat Soleno Therapeutics' score of 0.57 indicating that BioLife Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Soleno Therapeutics 7 Very Positive mention(s) 1 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 2 Very Negative mention(s) Positive Is BLFS or SLNO more profitable? Soleno Therapeutics has a net margin of 0.00% compared to BioLife Solutions' net margin of -5.39%. BioLife Solutions' return on equity of 0.16% beat Soleno Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-5.39% 0.16% 0.14% Soleno Therapeutics N/A -73.74%-56.67% Which has preferable earnings & valuation, BLFS or SLNO? BioLife Solutions has higher revenue and earnings than Soleno Therapeutics. BioLife Solutions is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$82.25M15.13-$20.18M-$0.12-216.50Soleno TherapeuticsN/AN/A-$175.85M-$4.14-12.01 SummaryBioLife Solutions beats Soleno Therapeutics on 8 of the 15 factors compared between the two stocks. Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition Export to ExcelMetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.24B$10.84B$5.73B$10.31BDividend YieldN/A1.89%5.90%4.63%P/E Ratio-216.4821.3875.8626.51Price / Sales15.1329.21528.72123.58Price / Cash210.5924.4737.1760.46Price / Book3.453.4312.796.29Net Income-$20.18M$212.47M$3.28B$270.51M7 Day Performance-1.59%-1.00%0.22%2.15%1 Month Performance6.74%2.17%4.61%6.35%1 Year Performance2.04%-10.93%68.33%25.48% BioLife Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions2.5702 of 5 stars$25.98+0.7%$31.29+20.4%+2.7%$1.24B$82.25M-216.48440Trending NewsSLNOSoleno Therapeutics4.4279 of 5 stars$72.30+3.6%$115.09+59.2%-3.2%$3.71BN/A-17.4630Short Interest ↑TMDXTransMedics Group2.6262 of 5 stars$105.58+1.5%$122.11+15.7%-24.5%$3.55B$441.54M54.70210Analyst ForecastNVSTEnvista3.8118 of 5 stars$21.14-0.8%$20.92-1.0%+8.8%$3.54B$2.51B66.0512,300Positive NewsLIVNLivaNova3.0716 of 5 stars$58.32+0.6%$59.71+2.4%+14.2%$3.17B$1.25B-14.992,900Positive NewsWRBYWarby Parker1.5028 of 5 stars$26.74+2.8%$24.06-10.0%+80.0%$2.74B$771.32M-382.003,780Positive NewsAnalyst UpgradeInsider TradeINSPInspire Medical Systems4.8967 of 5 stars$83.51-3.4%$164.50+97.0%-60.3%$2.56B$802.80M48.271,246Positive NewsLQDALiquidia Technologies3.6972 of 5 stars$27.98-3.0%$32.11+14.8%+173.3%$2.48B$14M-16.4650PRCTPROCEPT BioRobotics3.1429 of 5 stars$38.92-4.3%$73.22+88.1%-53.2%$2.26B$224.50M-25.11430Positive NewsAnalyst ForecastLMATLeMaitre Vascular3.1594 of 5 stars$97.07-0.4%$97.60+0.5%+3.0%$2.21B$219.86M47.12490Positive NewsAORTArtivion3.2325 of 5 stars$43.34-0.3%$40.63-6.2%+57.4%$2.05B$388.54M-103.191,600Positive News Related Companies and Tools Related Companies Soleno Therapeutics Competitors TransMedics Group Competitors Envista Competitors LivaNova Competitors Warby Parker Competitors Inspire Medical Systems Competitors Liquidia Technologies Competitors PROCEPT BioRobotics Competitors LeMaitre Vascular Competitors Artivion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLFS) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLFS Stock Alerts